Societal Cost of Coronavirus Disease (COVID-19) Mortality Using Value of Statistical Life

Societal Cost of Coronavirus Disease (COVID-19) Mortality Using Value of Statistical Life

Authors

Keywords:

Value of statistical life, causes of death, coronavirus (COVID-19) pandemic, societal costs, economic impact of the pandemic

Abstract

The study is devoted to estimating the societal cost of coronavirus disease (COVID-19) mortality in 2020 using the value of statistical life. According to official statistics, most deaths due to coronavirus are observed among older people. Since there is no consensus in the current scientific literature on whether value of life estimates need to be age-adjusted for purposes of cost-benefit analysis, both age-adjusted and age-invariant estimates are provided for comparison. The article presents three approaches to determining societal costs of the pandemic: using the average value of statistical life for the entire population, using a decreasing coefficient (senior discount) for older ages, and considering age-adjusted estimates of the value of statistical life, depending on life expectancy within age cohorts. According to the calculation results, the social damage from mortality due to COVID-19 in 2020 amounted to 41,721, 32,956-34,522, and 15,5 trillion rubles using the approaches mentioned above, respectively. All these values are significantly higher than the economic damage, amounting to just under 1 trillion rubles, according to Rospotrebnadzor. This example demonstrates the potential of using the value of statistical life estimates to analyze changes in social welfare and clearly illustrates how underestimating such changes distort overall damage estimates. The research results can be used in public administration and for scientific purposes for a comprehensive analysis of the coronavirus pandemic consequences for Russian society.

Author Biography

Ekaterina A. Zubova, Lomonosov Moscow State University

PhD student, Faculty of Economics, Lomonosov Moscow State University, Moscow, Russian Fedeartion; Fox Fellow (2021–2022), Yale University, New Haven, USA.

ekaterina.zubova@yale.edu

References

Зубова Е.А. Стоимость жизни в России: оценка на панельных микроданных за 2010–2020 гг. // Прикладная эконометрика. 2022a. № 1 (65). С. 45–64.

Зубова Е.А. Растет ли стоимость жизни человека в России с возрастом и повышением уровня образования? // Population and Economics. 2022b. № 6 (1). C. 62–79. DOI: 10.3897/popecon.5.e79796

Aldy J., Atkinson G., Kotchen M.J. Environmental Benefit-Cost Analysis: A Comparative Analysis Between the United States and the United Kingdom // Annual Review of Resource Economics. 2021. Vol. 13. P. 267–288. DOI: https://doi.org/10.1146/annurev-resource-040821-045913

Aldy J.E., Viscusi W.K. Age Differences in the Value of Statistical Life: Revealed Preference Evidence // Review of Environmental Economics and Policy. 2007. Vol. 1. Is. 2. P. 241–260.

Baker R., Chilton S., Jones-Lee M., Metcalf H. Valuing Lives Equally in a Benefit-Coast Analysis of Safety Projects: A Method to Reconcile Theory and Practice // Safety Science. 2009. Vol. 47. Is. 6. P. 813–816. DOI: https://doi.org/10.1016/j.ssci.2008.10.009

Banzhaf H.S. The Value of Statistical Life: A Meta-Analysis of Meta-Analyses // National Bureau of Economic Research Working Paper Series. 2021. № 29185. URL: https://www.nber.org/system/files/working_papers/w29185/w29185.pdf

Hammitt J. Valuing Mortality Risk: Theory and Practice // Environmental Science and Technology. 2000. Vol. 34. Is. 8. P. 1396–1400. DOI: https://doi.org/10.1021/es990733n

Krupnick A. Mortality-Risk Valuation and Age: Stated Preference Evidence // Review of Environmental Economics and Policy. 2007. Vol. 1. Is. 2. P. 261–282.

Murphy K.M., Topel R.H. The Value of Health and Longevity // Journal of Political Economy. 2006. Vol. 114. Is. 5. P. 871–904.

Robinson L.A., Sullivan R., Shogren J.F. Do the Benefits of COVID-19 Policies Exceed the Costs? Exploring Uncertainties in the Age-VSL Relationship // Risk Analysis: An Official Publication of the Society for Risk Analysis. 2021. Vol. 41. Is. 5. P. 761–770. DOI: https://doi.org/10.1111/risa.13561

Viscusi W.K. Pricing the Global Health Risks of the COVID-19 Pandemic // Journal of Risk and Uncertainty. 2020. Vol. 61. P. 101–128. DOI: https://doi.org/10.1007/s11166-020-09337-2

Viscusi W.K. The Value of Life: Estimates with Risks by Occupation and Industry // Economic Inquiry, Western Economic Association International. 2004. Vol. 42. Is. 1. P. 29–48. DOI: https://doi.org/10.1093/ei/cbh042

Viscusi W.K., Masterman C. Income Elasticities and Global Values of a Statistical Life // Journal of Benefit-Cost Analysis. 2017. Vol. 8. Is. 2. P. 226–250. DOI: https://doi.org/10.1017/bca.2017.12

Downloads

Published

2022-10-30

How to Cite

Societal Cost of Coronavirus Disease (COVID-19) Mortality Using Value of Statistical Life. (2022). Public Administration. E-Journal (Russia), 91, 173-192. https://spajournal.ru/index.php/spa/article/view/261

Issue

Section

Scientific articles

Categories

How to Cite

Societal Cost of Coronavirus Disease (COVID-19) Mortality Using Value of Statistical Life. (2022). Public Administration. E-Journal (Russia), 91, 173-192. https://spajournal.ru/index.php/spa/article/view/261

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >> 

Similar Articles

1-10 of 233

You may also start an advanced similarity search for this article.

Loading...